Teva Pharmaceutical Industries (NYSE:TEVA)

Stock Price

Teva, Gilead Sciences Tumble into Monday’s 52-Week Low Club

January 23, 2017: Here are four stocks trading with relatively heavy volume among 56 equities making new 52-week lows in Monday's session. On the NYSE, advancers led decliners by about 8 ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Stock Price

Macy’s, Teva Join Wednesday’s 52-Week Low Club

January 11, 2017: Here are four stocks trading with relatively heavy volume among 25 equities making new 52-week lows in Wednesday's session. On the NYSE, advancers led decliners by more ...
Read Full Story »
Unhealthy Person

3 Sleeper Biotechs That Could Bounce Back Strong in 2017

When traders look at a stock at its highs and imagine what would be had they gotten in at the lows, the thought that invariably gets triggered is “At the ...
Read Full Story »
Prescription drugs

Short Interest Rises in Major Pharma

The short interest data have been released for the December 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Prescription drugs

Short Sellers Back Way Off Major Pharma Stocks

The short interest data have been released for the November 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Stock Price

Teva, FitBit Settle into Tuesday’s 52-Week Low Club

December 6, 2016: Here are four stocks trading with relatively heavy volume among 35 equities making new 52-week lows in Tuesday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »
ThinkstockPhotos-481735362

Teva Shares Slide on Management Change

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) shares sank on Tuesday after the company announced a change in its management. The company has appointed Dipankar Bhattacharjee as chief executive for its ...
Read Full Story »
Stock Price

FitBit, Teva Slide into Monday’s 52-Week Low Club

December 2, 2016: Here are four stocks trading with relatively heavy volume among 42 equities making new 52-week lows in Monday's session. On the NYSE, advancers led decliners by about ...
Read Full Story »
Prescription drugs

Short Sellers Hike Their Bets in Most Major Pharma Stocks

The short interest data have been released for the November 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
investing

Hedge Funds Bought Apple, P&G in Q3; Dumped Allergan, Charter

Building on a turn toward more equity investments in the second quarter of this year, the top 50 hedge funds boosted their equity positions by 2.9% in the third quarter. ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Bank of America, Fitbit, Teva Pharma, Disney, Regions Financial, Noble, Sysco and More

Wednesday is looking like it could bring a down open for the Dow Jones Industrial Average. Before thinking it is a huge worry, keep in mind that the market is ...
Read Full Story »
Stock Price

Nokia, Teva Plunge into Tuesday’s 52-Week Low Club

November 15, 2016: Here are four stocks trading with relatively heavy volume among 40 equities making new 52-week lows in Tuesday's session. On the NYSE, advancers led decliners by nearly ...
Read Full Story »
lifestyle photo of a young caucasian man as he waits in a hospital examination room

Why Teva Sank Despite Solid Earnings and Guidance

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) released its third-quarter earnings reports before the markets opened on Tuesday. Despite underperforming this year, it has truly been a time of transition for ...
Read Full Story »
Pills and tablets

What to Look for in Teva Pharmaceuticals Earnings

Teva Pharmaceuticals Industries Ltd. (NYSE: TEVA) is set to release its third-quarter financial results before the markets open on Tuesday. This company has so far been unable to escape its ...
Read Full Story »